Profile
Martin P.
Redmon is currently the Chief Research & Development Officer at Stealth BioTherapeutics Corp.
He previously held the position of Senior Vice President-Research & Development at PreCision Dermatology, Inc. and Chief Research & Development Officer at Stealth BioTherapeutics, Inc. Dr. Redmon obtained undergraduate and doctorate degrees from the University of Kentucky.
Martin Redmon active positions
| Companies | Position | Start |
|---|---|---|
| STEALTH BIOTHERAPEUTICS CORP | Chief Tech/Sci/R&D Officer | 16/03/2021 |
Former positions of Martin Redmon
| Companies | Position | End |
|---|---|---|
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat the mitochondrial dysfunctions and age-related diseases | Chief Tech/Sci/R&D Officer | - |
PreCision Dermatology, Inc.
PreCision Dermatology, Inc. Pharmaceuticals: MajorHealth Technology Develops skincare therapies | Chief Tech/Sci/R&D Officer | - |
Training of Martin Redmon
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
PreCision Dermatology, Inc.
PreCision Dermatology, Inc. Pharmaceuticals: MajorHealth Technology Develops skincare therapies | Health Technology |
University of Kentucky
University of Kentucky Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stealth BioTherapeutics Corp.
Stealth BioTherapeutics Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops investigational drugs for the treatment of diseases involving mitochondrial dysfunction | Health Technology |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat the mitochondrial dysfunctions and age-related diseases | Health Technology |
- Stock Market
- Insiders
- Martin Redmon
















